Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 27 Classical hematology 14 Other hematologic neoplasm 10 Genitourinary 10 Lymphoid 4 CNS 4 Thoracic 3 Plasma cell 3 Other 2 Myeloid 2 Gynecologic 2 Endocrine 2 Sarcoma 1 Head & Neck 1

Conditions

Sarcoma 1573 Glioblastoma 512 Gliosarcoma 485 Osteosarcoma 459 Brain Neoplasms 344 Gastrointestinal Stromal Tumors 326 Central Nervous System Neoplasms 296 Neoplasms 291 Dendritic Cell Sarcoma, Interdigitating 286 Astrocytoma 275 Lymphoma 260 Bone Neoplasms 245 Sarcoma, Ewing 238 Breast Neoplasms 238 Glioma 237 Neuroblastoma 230 Rhabdomyosarcoma 227 Melanoma 225 Precursor Cell Lymphoblastic Leukemia-Lymphoma 218 Recurrence 216 Lymphoma, Non-Hodgkin 216 Burkitt Lymphoma 213 Oligodendroglioma 203 Ovarian Neoplasms 202 Lymphoma, Large B-Cell, Diffuse 187 Neoplasm Metastasis 186 Lymphoma, Follicular 172 Leukemia 164 Leukemia, Lymphocytic, Chronic, B-Cell 158 Hodgkin Disease 158

Interventions

Tranexamic Acid 1 Fibrin Tissue Adhesive 1 Diathermy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hemorrhage × Sarcoma × Clear all

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡